Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-23-000134
Filing Date
2023-01-23
Accepted
2023-01-23 12:34:33
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING HERON THERAPEUTICS, INC. HERON_THERAPEUTICS_INC.htm SC 13G/A 87981
  Complete submission text file 0000019617-23-000134.txt   90002
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444
SIC: 2834 Pharmaceutical Preparations